Anne Bruns

Anne is a solution-oriented leader dedicated to bringing patient insights to innovation and drug development teams at PTC at the global level. She provides strategic and operational leadership to the patient interface component of clinical trials and provides synergy between Patient Engagement, Clinical Operations, Commercial Development, and other internal stakeholders.

Prior to her current role, Anne was part of the Patient Engagement Neurology team at PTC and supported families in the Duchenne muscular dystrophy community. As a former nonprofit rare disease leader, she continues to be an influencer within the community and build relationships across the world in all rare disease communities.

Anne brings a valuable perspective to the corporate community at PTC with her direct understanding of the unique social and emotional needs of the rare disease community. She provides sound strategic plans to support the drug development process and increase awareness of the pipeline programs at PTC.